Skip to content

Clinical trials

Phase 1 Lymphoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 1 Country / region: Italy Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20113
20121
20132
20141
20161
20173
20181
20192
20202
20222
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated7
Recruiting3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Hutchmed2
Novartis Pharmaceuticals2
ADC Therapeutics S.A.1
Armando Santoro, MD1
Bellicum Pharmaceuticals1
Biomea Fusion Inc.1
Boston Medical Center1
Byondis B.V.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma22
Lymphoma, Non-Hodgkin9
Lymphoma, Large B-Cell, Diffuse8
Neoplasms6
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, Follicular5
Lymphoma, Mantle-Cell4
Recurrence4
Hodgkin Disease3
Multiple Myeloma3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.